AstraZeneca has made a tender offer to acquire Icosavax's shares for $15 per share, with a contingent value right worth up to $5.The CVR includes milestone payouts based on FDA approval and net sales ...
Source LinkAstraZeneca has made a tender offer to acquire Icosavax's shares for $15 per share, with a contingent value right worth up to $5.The CVR includes milestone payouts based on FDA approval and net sales ...
Source Link
Comments